199 related articles for article (PubMed ID: 26589727)
1. Early aspirin desensitization in unstable patients with acute coronary syndrome: Short and long-term efficacy and safety.
Córdoba-Soriano JG; Corbí-Pascual M; López-Neyra I; Navarro-Cuartero J; Hidalgo-Olivares V; Barrionuevo-Sánchez MI; Prieto-Mateos D; Gutiérrez-Díez A; Gallardo-López A; Fuentes-Manso R; Gómez-Pérez A; Lafuente-Gormaz C; Jiménez-Mazuecos J
Eur Heart J Acute Cardiovasc Care; 2016 Nov; 5(7):41-50. PubMed ID: 26589727
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Desensitization in Patients With Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease).
Rossini R; Iorio A; Pozzi R; Bianco M; Musumeci G; Leonardi S; Lettieri C; Bossi I; Colombo P; Rigattieri S; Dossena C; Anzuini A; Capodanno D; Senni M; Angiolillo DJ
Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193678
[TBL] [Abstract][Full Text] [Related]
3. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
[TBL] [Abstract][Full Text] [Related]
4. Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience.
De Luca G; Verdoia M; Binda G; Schaffer A; Suryapranata H; Marino P
Int J Cardiol; 2013 Jul; 167(2):561-3. PubMed ID: 22365313
[TBL] [Abstract][Full Text] [Related]
5. Rapid Aspirin Desensitization is Safe and Feasible in Patients With Stable and Unstable Coronary Artery Disease: A Single-Center Experience.
Jackson M; Callaghan S; Stapleton J; Bolton S; Austin D; Muir DF; Sutton AGC; Wright RA; Williams PD; Hall JA; Carter J; de Belder MA; Swanson N
J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):359-364. PubMed ID: 30614246
[TBL] [Abstract][Full Text] [Related]
6. Establishing a Safe Administration of ASA in Cardiovascular Patients with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity with Skin and/or Respiratory Involvement.
Al-Ahmad M; Rodriguez-Bouza T; Nurkic M
Int Arch Allergy Immunol; 2018; 175(4):237-245. PubMed ID: 29393216
[TBL] [Abstract][Full Text] [Related]
7. Aspirin desensitisation for Chinese patients with coronary artery disease.
Lee JK; Tsui KL; Cheung CY; Chau CH; Chan HL; Wu KL; Cheung GS; Choi MC; Chan KK; Li SK
Hong Kong Med J; 2013 Jun; 19(3):207-13. PubMed ID: 23650199
[TBL] [Abstract][Full Text] [Related]
8. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.
Silberman S; Neukirch-Stoop C; Steg PG
Am J Cardiol; 2005 Feb; 95(4):509-10. PubMed ID: 15695141
[TBL] [Abstract][Full Text] [Related]
9. [Acetylsalicylic acid desensitization in the new era of percutaneous coronary intervention].
Fuertes Ferre G; Ferrer Gracia MC; Calvo Cebollero I
Med Clin (Barc); 2015 Sep; 145(6):253-7. PubMed ID: 25577589
[TBL] [Abstract][Full Text] [Related]
10. [Rapid aspirin desensitization in patients with a history of aspirin hypersensitivity requiring coronary angioplasty. Report of four cases].
Veas P N; Martínez G; Jalil M J; Martínez S A; Castro G P
Rev Med Chil; 2013 Feb; 141(2):255-9. PubMed ID: 23732500
[TBL] [Abstract][Full Text] [Related]
11. Effect of rapid desensitization on platelet inhibition and basophil activation in patients with aspirin hypersensitivity and coronary disease.
Manzo-Silberman S; Nicaise-Roland P; Neukirch C; Tubach F; Huisse MG; Chollet-Martin S; Abergel H; Driss F; Alfaiate T; Ajzenberg N; Steg PG
Eur Heart J Cardiovasc Pharmacother; 2017 Apr; 3(2):77-81. PubMed ID: 27533953
[TBL] [Abstract][Full Text] [Related]
12. Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy.
Page NA; Schroeder WS
Ann Pharmacother; 2007 Jan; 41(1):61-7. PubMed ID: 17200429
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity to aspirin and urgent percutaneous coronary intervention: A therapeutic challenge.
Duarte T; Gonçalves S; Sá C; Marinheiro R; Rodrigues R; Seixo F; Tomas E; Caria R
Rev Port Cardiol; 2016 Nov; 35(11):619.e1-619.e5. PubMed ID: 27717518
[TBL] [Abstract][Full Text] [Related]
14. [Desensitization in drug hypersensitivity].
Piotrowicz-Wójcik K; Porebski G; Czarnobilska E
Przegl Lek; 2013; 70(12):1008-10. PubMed ID: 24720117
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
Fajt M; Petrov A
Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
[TBL] [Abstract][Full Text] [Related]
16. Aspirin Hypersensitivity in Patients Undergoing Percutaneous Coronary Intervention. What Should We be Doing?
Kassimis G; Raina T; Alexopoulos D
Curr Vasc Pharmacol; 2019; 17(4):326-331. PubMed ID: 29866010
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
Yu J; Mehran R; Dangas GD; Claessen BE; Baber U; Xu K; Parise H; Fahy M; Lansky AJ; Witzenbichler B; Grines CL; Guagliumi G; Kornowski R; Wöhrle J; Dudek D; Weisz G; Stone GW
JACC Cardiovasc Interv; 2012 Dec; 5(12):1231-8. PubMed ID: 23257371
[TBL] [Abstract][Full Text] [Related]
18. Meta-Analysis of Acetylsalicylic Acid Desensitization in Patients With Acute Coronary Syndrome.
Chopra AM; Díez-Villanueva P; Córdoba-Soriano JG; Lee JKT; Al-Ahmad M; Ferraris VA; Mehta M; Kowalski ML
Am J Cardiol; 2019 Jul; 124(1):14-19. PubMed ID: 31027657
[TBL] [Abstract][Full Text] [Related]
19. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
Xia JG; Qu Y; Shen H; Liu XH
Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
[TBL] [Abstract][Full Text] [Related]
20. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
